• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.

作者信息

Hightower Stephanie, Ellis Harvey, Collen Jacob, Ellis John, Grasso Ian, Roswarski Joseph, Cap Andrew P, Chung Kevin, Prescher Lindsey, Kavanaugh Michael, Brown Tara, Nau Mark, Clark Paul

机构信息

Department of Pulmonary, Critical Care and Sleep Medicine, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA.

Department of Cardiothoracic Surgery, Walter Reed National Military Medical Center, USA.

出版信息

Thromb Res. 2020 Nov;195:69-71. doi: 10.1016/j.thromres.2020.07.013. Epub 2020 Jul 9.

DOI:10.1016/j.thromres.2020.07.013
PMID:32659463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7346789/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4780/7346789/f4dcef1518cd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4780/7346789/f4dcef1518cd/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4780/7346789/f4dcef1518cd/gr1_lrg.jpg

相似文献

1
Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.2019年重症冠状病毒感染中高凝状态间接标志物与血栓弹力图的相关性
Thromb Res. 2020 Nov;195:69-71. doi: 10.1016/j.thromres.2020.07.013. Epub 2020 Jul 9.
2
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
3
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者入院时的循环纤溶酶原浓度
Semin Thromb Hemost. 2020 Oct;46(7):859-862. doi: 10.1055/s-0040-1715454. Epub 2020 Sep 3.
4
Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.危重症新型冠状病毒肺炎感染患者表现出与高凝状态一致的凝血波形分析参数增加。
Am J Hematol. 2020 Jul;95(7):E156-E158. doi: 10.1002/ajh.25822. Epub 2020 May 4.
5
Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?先天性出血性疾病患者似乎受严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）的影响较小：遗传性低凝状态是否克服了2019冠状病毒病（COVID-19）的获得性高凝状态？
Semin Thromb Hemost. 2020 Oct;46(7):853-855. doi: 10.1055/s-0040-1713435. Epub 2020 Jun 18.
6
Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.简要研究：新型冠状病毒肺炎中的凝血功能障碍：确定和管理新型冠状病毒肺炎感染中的血栓形成风险
Clin Med (Lond). 2020 Jul;20(4):e59. doi: 10.7861/clinmed.rib.20.4.2.
7
Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019.新冠肺炎危重症患者的血栓弹力描记图特征。
Crit Care Med. 2020 Sep;48(9):1319-1326. doi: 10.1097/CCM.0000000000004471.
8
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.新冠肺炎癌症患者的血栓形成与止血问题
Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.
9
COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
10
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.严重 COVID-19 高凝状态下常规静脉血栓栓塞预防可能不足。
Crit Care Med. 2020 Sep;48(9):e783-e790. doi: 10.1097/CCM.0000000000004466.

引用本文的文献

1
Clinical Characteristics and Laboratory Findings in Children with Multisystem Inflammatory Syndrome (MIS-C)-A Retrospective Study of a Tertiary Care Center from Constanta, Romania.多系统炎症综合征（MIS-C）患儿的临床特征与实验室检查结果——罗马尼亚康斯坦察一家三级医疗中心的回顾性研究
Healthcare (Basel). 2023 Feb 12;11(4):544. doi: 10.3390/healthcare11040544.
2
Thromboelastography determined dynamics of blood coagulation and its correlation with complications and outcomes in patients with coronavirus disease 2019.血栓弹力图测定2019冠状病毒病患者的血液凝固动力学及其与并发症和预后的相关性。
Res Pract Thromb Haemost. 2022 Jan 15;6(1):e12645. doi: 10.1002/rth2.12645. eCollection 2022 Jan.
3

本文引用的文献

1
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum.COVID-19 大流行期间的血栓栓塞和抗凝治疗：抗凝论坛的临时临床指南。
J Thromb Thrombolysis. 2020 Jul;50(1):72-81. doi: 10.1007/s11239-020-02138-z.
2
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
3
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
Evaluation of coagulation with TEG in patients diagnosed COVID-19.
评估诊断为 COVID-19 的患者的 TEG 凝血情况。
Turk J Med Sci. 2022 Feb;52(1):1-10. doi: 10.3906/sag-2106-379. Epub 2022 Feb 22.
4
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.SARS-CoV-2 相关 COVID-19 呼吸衰竭患者应用阿替普酶的研究：一项先锋性、快速适应、实用、随机对照试验。
Chest. 2022 Mar;161(3):710-727. doi: 10.1016/j.chest.2021.09.024. Epub 2021 Sep 27.
5
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.用于评估新型冠状病毒肺炎止血功能的粘弹性测试：一项系统评价
J Clin Med. 2021 Apr 16;10(8):1740. doi: 10.3390/jcm10081740.
6
COVID-19 in thrombosis research: An editorial perspective.血栓形成研究中的新冠病毒病：编辑视角
Thromb Res. 2021 May;201:147-150. doi: 10.1016/j.thromres.2021.03.011. Epub 2021 Mar 24.
7
Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.COVID-19 中的纤维蛋白溶解关闭：临床特征、分子机制和治疗意义。
J Am Coll Surg. 2021 Jun;232(6):995-1003. doi: 10.1016/j.jamcollsurg.2021.02.019. Epub 2021 Mar 22.
8
The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review.血栓弹力图分析在新型冠状病毒肺炎相关凝血病患者中的作用：一项系统评价
Diagnostics (Basel). 2021 Jan 26;11(2):172. doi: 10.3390/diagnostics11020172.
9
Thromboelastography Profile of Patients with COVID-19 Admitted to Intensive Care Unit: A Single-center Retrospective Study from India.入住重症监护病房的 COVID-19 患者的血栓弹力图分析：一项来自印度的单中心回顾性研究。
Indian J Crit Care Med. 2020 Dec;24(12):1218-1222. doi: 10.5005/jp-journals-10071-23675.
确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
4
Severe COVID-19 infection associated with endothelial activation.严重的2019冠状病毒病感染与内皮细胞激活有关。
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
5
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
6
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成：五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
7
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
8
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility.升高的纤溶酶原作为 COVID-19 易感性的常见危险因素。
Physiol Rev. 2020 Jul 1;100(3):1065-1075. doi: 10.1152/physrev.00013.2020. Epub 2020 Mar 27.
9
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
10
Relation of thromboelastography parameters to conventional coagulation tests used to evaluate the hypercoagulable state of aged fracture patients.血栓弹力图参数与用于评估老年骨折患者高凝状态的传统凝血试验之间的关系。
Medicine (Baltimore). 2016 Jun;95(24):e3934. doi: 10.1097/MD.0000000000003934.